PROFOUND MEDICAL CORP. Cash And Cash Equivalents
PROFOUND MEDICAL CORP. (PROF) had Cash And Cash Equivalents of $26.21 million as of 2023-12-31, per its 40-F filed 2024-03-07.
Discontinued › Assets
ifrs-full:CashAndCashEquivalents · last filed 2024-03-07
- 2019-12-31: Cash And Cash Equivalents 19.22M CAD; Cash And Cash Equivalents as first filed 19.22M CAD.
- 2019-01-01: Cash And Cash Equivalents 30.69M CAD.
- 2018-12-31: Cash And Cash Equivalents 30.69M CAD.
- 2017-12-31: Cash And Cash Equivalents 11.10M CAD.
CAD
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2019-12-31 | 19.22M CAD 40-F · filed 2021-03-02 | 19.22M CAD 40-F · filed 2020-03-03 |
| 2019-01-01 | 30.69M CAD 40-F · filed 2021-03-02 | |
| 2018-12-31 | 30.69M CAD 40-F · filed 2020-03-03 | |
| 2017-12-31 | 11.10M CAD 40-F · filed 2020-03-03 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2023-12-31 | $26.21M 40-F · filed 2024-03-07 |
| 2022-12-31 | $46.52M 40-F · filed 2024-03-07 |
| 2021-12-31 | $67.15M 40-F · filed 2024-03-07 |
| 2020-12-31 | $83.91M 40-F · filed 2023-03-07 |
| 2019-12-31 | $14.80M 40-F · filed 2022-03-03 |
| 2019-01-01 | $22.50M 40-F · filed 2021-03-02 |
| 2018-12-31 | $22.50M 40-F · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |